Related Experiment Video
Updated: Jul 18, 2026
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
[Severe breathlessness in a patient presenting with chronic bronchitis]
1Laboratoire de Physiologie, Faculté de Médecine de Nancy, EA 3450, Service des Explorations Fonctionnelles Respiratoires, Centre Hospitalier Universitaire de Nancy, Vandoeuvre-lès-Nancy, France.
Revue Des Maladies Respiratoires
|November 28, 2006
Summary
Hyperventilation syndrome can cause significant breathlessness in Chronic Obstructive Pulmonary Disease (COPD) patients. Diagnosis requires distinguishing subjective symptoms from objective lung function changes.
Area of Science:
- Respiratory Medicine
- Neuroscience
- Pulmonary Physiology
Background:
- Dyspnoea is a primary symptom in Chronic Obstructive Pulmonary Disease (COPD).
- Respiratory control involves complex supra-bulbar structures, similar to pain perception.
- Hyperventilation syndrome can cause dyspnoea independent of peripheral respiratory signals.
Observation:
- A case of GOLD stage 0 COPD is presented.
- The patient experienced significant daily activity limitations.
- Repetitive hyperventilation periods, triggered by supra-bulbar influences, caused persistent dyspnoea.
Findings:
- Supra-bulbar influences on respiratory control can significantly impact COPD patients.
- Hyperventilation syndrome may present atypically in patients with underlying respiratory disease.
- A discrepancy between subjective dyspnoea and objective lung function is a key diagnostic clue.
Implications:
- This case highlights the importance of considering central respiratory control mechanisms in COPD symptomology.
- Accurate diagnosis of hyperventilation syndrome in COPD requires careful clinical assessment and specific testing.
- Understanding supra-bulbar influences may lead to novel therapeutic strategies for COPD-related dyspnoea.
Related Concept Videos
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD: